Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue
Date:11/3/2010

ns

142376186310Dilutive effect of convertible senior notes (4)5,8015,801-5,801Non-GAAP diluted shares (3)68,65066,42562,74864,312Non-GAAP net income per share (3)$
.88$
.37$
.91$
.78Non-GAAP net income per share - diluted (3) $
.84$
.35$
.90$
.73(3)
This press release includes the following non-GAAP financial measures: non-GAAP net income, non-GAAP net income – diluted, non-GAAP net income per share, and non-GAAP net income per share – diluted. The foregoing table reconciles these non-GAAP measures to the most comparable financial measures calculated in accordance with GAAP.Onyx management uses these non-GAAP financial measures to monitor and evaluate our operating results and trends on an on-going basis and internally for operating, budgeting and financial planning purposes. Onyx management believes the non-GAAP information is useful for investors by offering them the ability to better identify trends in our business and better understand how management evaluates the business. These non-GAAP measures have limitations, however, because they do not include all items of income and expense that affect Onyx. These non-GAAP financial measures that management uses are not prepared in accordance with, and should not be considered in isolation of, or an as alternative to, measurements required by GAAP.These non-GAAP financial measures exclude the following items from GAAP net income (loss) and diluted per share amounts:Contingent consideration expense
: The effects of contingent consideration expense are excluded due to the nature of this charge, which is related to the change in fair value of the liability for contingent consideration in connection with the acquisition of Proteolix; such exclusion facilitates comparisons of Onyx's operating results to peer companies.Employee stock-based compensation
: The effects of employee stock-based compensation are excluded because of varying available valuation m
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Vanda Pharmaceuticals Reports Third Quarter 2010 Results
2. OncoMed Pharmaceuticals Awarded Five Therapeutic Discovery Project Grants Totaling $1.2 Million
3. Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010
4. Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
5. ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results
6. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
7. Access Pharmaceuticals Awarded $1.5 Million in Section 48D Grants
8. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
9. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
10. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
11. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... that address unmet medical needs in the areas ... on December 24, 2014 it closed its previously ... raised approximately $2.3 million in gross proceeds from ... proceeds from the offering to fund its research ...
(Date:12/24/2014)... LONDON , December 24, 2014 /PRNewswire/ ... expected to grow at an average rate of 8.1%. ... and volume. Hip, knee and spine surgeries are the ... emerging economies they have a lower penetration. Increased number ... use of composites. Non-metallic orthopedic devices have gained popularity ...
(Date:12/24/2014)... DALLAS , December 24, 2014 /PRNewswire/ ... Research Report on Global Disposable Syringe Industry ... to its online business intelligence library. ... Global Disposable Syringe Industry is a professional ... Syringe market.  For overview analysis, the report ...
Breaking Medicine Technology:Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5
... its commitment to the hemophilia community, Bayer HealthCare is ... adding a community element to the internship experience.  The ... will spend five weeks of the eight-week program at ... is currently seeking applicants who are attending college and ...
... Canon Europe, world-leader in imaging solutions, has strengthened ... Netherlands-based Medical solutions specialist Delft Diagnostic Imaging (Delft DI). ...  The first area is innovative medical software solutions for ... become a future platform for the development of new ...
Cached Medicine Technology:Bayer Expands Its Hemophilia Leadership Development Program 2Bayer Expands Its Hemophilia Leadership Development Program 3Canon Europe Acquires Dutch Medical Solutions Specialist Delft DI 2
(Date:12/26/2014)... 26, 2014 The Biofeedback Federation of ... 24-28, 2015 in Rome, Italy and is hosted by ... workshops on a wide variety of topics such ... peak performance training in athletes. The scientific program will ... , Biofeedback monitoring allows clients to see what is ...
(Date:12/26/2014)... DW-InductionHeating.com (DaWei Induction Heating Co.) is a ... producing and marketing of a series of induction heating ... new series of induction brazing equipments . , ... induction brazing refers to the joining of two ... heat. The manager says that there are fundamental differences ...
(Date:12/25/2014)... 26, 2014 The report “Nintedanib ... 2023” focuses on the current treatment landscape, unmet ... colorectal cancer market. Stivarga is a drug which ... rectal cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), ... of refractory CRC in the US, Europe, and ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online ... its collection of discounted prom dresses, most of which ... spokesman of the company, the promotion is valid until ... to expand the UK market. , The prom dresses ... lengths, and styles: A-line strapless, empire strapless chiffon, one ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 When head lice ... themselves in a frenzy to get rid of it while ... families in Coral Gables now have the solution right in ... salon clinic location, Lice Troopers provides full spectrum head lice ... Coral Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, ...
Breaking Medicine News(10 mins):Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2
... diagnosed incidentally and asymptomatic, 12% to 27 % ... with duodenal diverticula suffer from clinical symptoms. Furthermore, ... various complications such as perforation, hemorrhage, and biliary/pancreatic/gastrointestinal ... the rare complications of diverticulum, based on the ...
... , CHICAGO, Aug. 25 MRSA ... MRSA Day Kick-off event on October 1st in Chicago at Loyola ... the U.S. on October 2nd and throughout the month of October, ... http://www.newscom.com/cgi-bin/prnh/20090825/DC65136LOGO ) , , The historic day ...
... Aug. 25 Zargis Medical Corp., a spin-off from Siemens Corporate Research ... (Nasdaq: SPDE ), today announced that it has begun selling ... MMM ) j u st-released ... previously a n nounced exclusive multi-year global ...
... , AUSTIN, Texas, Aug. 25 Scalpure, LLC ... l oss and proving how effective their ... reporting unprecedented results. Scalpure is available exclusively at http://www.Scalpure.com. ... product that everyone can benefit from. Scalpure creates and maintains ...
... , , , ... NASHVILLE, Tenn., Aug. 25 HealthLeaders-InterStudy, a leading provider of managed care ... consolidated than most large cities, with multiple large physician groups affiliated with ... in the future. According to the recent Chicag o ...
... , , MILWAUKEE, Aug. 25 ... habits, says a national survey by Bradley Corporation, a leading manufacturer ... In Bradley,s first Healthy Hand Washing Survey, 54 percent said ... restrooms since the H1N1 virus emerged. , , ...
Cached Medicine News:Health News:MRSA Survivor to Launch First World MRSA Day 2Health News:Zargis Cardioscan(TM) Unveiled Through Global Marketing and Distribution Alliance With 3M Company 2Health News:Zargis Cardioscan(TM) Unveiled Through Global Marketing and Distribution Alliance With 3M Company 3Health News:Zargis Cardioscan(TM) Unveiled Through Global Marketing and Distribution Alliance With 3M Company 4Health News:Hair Loss Being Conquered 2Health News:Consolidation Among Chicago Physicians Likely to Increase 2Health News:Consolidation Among Chicago Physicians Likely to Increase 3Health News:Despite H1N1 Flu Threat, Most Americans Haven't Increased Hand Washing 2
An indirect immunofluorescence (IFA) antibody test for the detection and semiquantitation of anti-glomerular basement membrane (GBM) antibodies in human serum. Slide Detail: 6-well Monkey Kidney Subs...
An enzyme linked immunoassay (ELISA) for the detection and semiquantitationof IgG and IgM antibodies to 2-GP1, as an aid in assessingthe risk of thrombosis in patients with Systemic Lupus Erythematos...
... NEW Research Grade Microscope Camera ... a superior imaging technology that delivers ... accuracy at an affordable price. ... high resolution 3.3 mega-pixel digital microscope ...
The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Zeiss surgical...
Medicine Products: